Understand the Strategy and Structure of Healthcare Transactions With the Assistance of This Video Seminar With Christopher Jedrey of Mcdermott Will & Emery LLP
Posted on: Friday, 11 January 2008, 12:01 CST
Research and Markets (http://www.researchandmarkets.com/reports/c79294) has announced the addition of Healthcare Law Transactions: Case Studies, Strategies & Analysis - Video Seminar with Christopher Jedrey of McDermott Will & Emery LLP to their offering.
The goal of this Video Seminar is to provide lawyers and executives with essential information about understanding the strategy and structure of healthcare transactions. The DVD is viewable on any computer or iPod (that supports video) and features 45 minutes of live video with Chris Jedrey of McDermott Will & Emery LLP, sharing his knowledge of best practices for health care transactions. The video seminar provides specific examples of healthcare case studies, the legal side of healthcare transactions and discusses compliance and various strategies.
Topics covered in the Video Seminar include:
- The basics and background of healthcare cases & transactions
- An in depth look at the steps of a various client cases
- The legal side of healthcare issues
- Laws, compliance & strategy
- Case Study - Working with a Catholic Healthcare Organization
Samples of the types of questions answered in the video seminar include:
- Which areas of healthcare law do you find presents the most challenging cases? Why?
- What trends are you seeing in healthcare law? How are your clients and cases different today than they were two years ago?
- What analysis do you conduct when preparing the strategy? How is this accomplished? What resources are used?
- What process is used to analyze and then minimize the client risks? In each case, how does the client's risk tolerance influence the strategy?
- Which elements of healthcare law are the hardest to develop, strategically? Why? Which have been present in your most recent cases?
- What is your general strategy for approaching healthcare cases? What are the legal challenges and how do you customize a strategy for each client?
- What are the most common outcomes for healthcare cases? What do you like to see as the outcome for your client cases? How do you measure success?
About Christopher Jedrey:
Christopher M. Jedrey is a partner in the law firm of McDermott Will & Emery LLP, based in the Firm's Boston office. He is partner-in-charge of its Boston Health practice, and national co-chairman of its Academic Medical Center practice. Chris represents providers and HMO clients in mergers, acquisitions, and joint ventures, sales of non-profit assets and operations to for-profit companies, and conversions from taxable to tax-exempt status. He represents academic medical centers for a variety of matters, including strategic affiliations, clinical research and faculty practice plans. Chris advises hospitals, colleges, universities, museums and other tax-exempt organizations on structuring executive compensation plans.
For more information visit http://www.researchandmarkets.com/reports/c79294
Source: Business Wire
Related Articles
- ATTUS Technologies, Inc. Processes Three Billion Annual Client Transactions
- Donald K. Warwick Joins the Litigation Healthcare Section of the Law Firm of Giarmarco, Mullins & Horton, P.C.
- Victory Marketing Group, Inc. Announces New VP of Strategy and Client Services
- Mark Cuban to Speak at Light Reading's Cable Next-Gen Video Strategies Conference
- Streamlining Healthcare Interactions and Processes Through Automated Transactions Between Healthplans and Physicians/Hospitals
- Verizon to File First Application Under New Jersey's New Pro-Consumer Video Franchise Law
- HealthTrans Reports Generic Utilization Exceed 60% for 1st Q '06; Client Duane Reade Presents Case Study at Annual Broker/TPA/Consultant Forum
- High Court to Hear Case on Abortion Law Late-Term Procedure Was Outlawed in '03
- Michael Critelli Addresses the Role of Executive Leadership in Wellness Initiatives and Healthcare Cost Containment Strategies
- Law Firms Prepare for Celebrex Cases After Pfizer Says 1999 Trial Revealed Cardiovascular Risks, Says Weitz & Luxenberg
User Comments (0)

RSS Feeds